Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 

Slides:



Advertisements
Similar presentations
Primary Prevention of Colorectal Cancer
Advertisements

Intermyocellular fat depot
Figure 2 Inflammatory pathways affecting hepatic insulin resistance
Cellular and Molecular Mechanisms of Liver Injury
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
From Fat to Inflammation
Obesity and Cancer: The Oil that Feeds the Flame
Volume 153, Issue 3, Pages e7 (September 2017)
Volume 47, Issue 3, Pages (September 2017)
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Primary Prevention of Colorectal Cancer
Volume 17, Issue 6, Pages (June 2013)
Ischemic cardiovascular involvement in psoriasis: A systematic review
Hepcidin in human iron disorders: Therapeutic implications
Volume 47, Issue 1, Pages (July 2007)
Obesity Heats Up Adipose Tissue Lymphocytes
Cellular and Molecular Mechanisms of Liver Injury
Volume 142, Issue 6, Pages (May 2012)
Nonalcoholic steatohepatitis
Microbial Influences in Inflammatory Bowel Diseases
The Role of CNS Fuel Sensing in Energy and Glucose Regulation
Volume 140, Issue 7, Pages (June 2011)
Roles for Chemokines in Liver Disease
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Ischemic cardiovascular involvement in psoriasis: A systematic review
Fishing Out a Sensor for Anti-inflammatory Oils
TNF-α–induced protein 3 (A20): The immunological rheostat
Frank J. Gonzalez, Changtao Jiang, Andrew D. Patterson 
ER stress-induced inflammation: does it aid or impede disease progression?  Abhishek D. Garg, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri.
Is REDD1 a Metabolic Éminence Grise?
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer  Ilya Gukovsky, Ning Li, Jelena Todoric,
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Figure 1 The insulin signalling pathway
Playtime Prevents Obesity by Brain-Mediated Fat Browning
The Cell Biology of the Unfolded Protein Response
Inflammation and intracellular metabolism: new targets in OA
The paradox of neuronal insulin action and resistance in the development of aging- associated diseases  Sophie M. Steculorum, Maite Solas, Jens C. Brüning 
IKKɛ: A Bridge between Obesity and Inflammation
Volume 134, Issue 4, Pages (April 2008)
Volume 146, Issue 7, Pages (June 2014)
Autophagy, Microbial Sensing, Endoplasmic Reticulum Stress, and Epithelial Function in Inflammatory Bowel Disease  Arthur Kaser, Richard S. Blumberg 
Selective Insulin and Leptin Resistance in Metabolic Disorders
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Volume 69, Issue 4, Pages (October 2018)
HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
Innate sensors of pathogen and stress: Linking inflammation to obesity
Volume 140, Issue 6, Pages (March 2010)
Estrogen Receptors and the Metabolic Network
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
Volume 146, Issue 4, Pages e1 (April 2014)
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 70, Issue 10, Pages (November 2006)
Banking on ATM as a new target in metabolic syndrome
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Insulin Resistance in the Defense against Obesity
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Volume 142, Issue 4, Pages e6 (April 2012)
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 
Sander Lefere, Frank Tacke  JHEP Reports 
Macrophages, Immunity, and Metabolic Disease
Adipose tissue, adipokines, and inflammation
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance  Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology  Volume 131, Issue 3, Pages 934-945 (September 2006) DOI: 10.1053/j.gastro.2006.05.054 Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 1 TNFα and adiponectin interplay in various biological systems, particularly in metabolic homeostasis. TNFα, a key proinflammatory cytokine synthesized by many cell types, including adipocytes, is a pleiotropic mediator of the immune system. Adiponectin is the abundant fat cell–derived product with important metabolic and immune functions. These 2 key mediators control the synthesis and activity of each other and thereby allow a balanced physiologic situation. This could be of key importance in diseases associated with IR because the critical balance might be impaired, leading to chronic inflammation. Such an imbalance might directly lead to IR. Besides suppressing TNFα adiponectin has several other anti-inflammatory features (eg, induction of other anti-inflammatory cytokines such as IL-10 and IL-1–receptor antagonist). Adiponectin stimulates glucose use and fatty acid oxidation by activating AMP-activated protein kinase (AMPK). It also increases the transcriptional regulator peroxisome proliferator-activated receptor γ coactivator α (PGC-1α) that is required for adiponectin-induced up-regulation of PPARα. FFAs induce TNFα expression and injury in the liver and lead to lysosomal destabilization with release of cathepsin B. Lysosomal destabilization leads to activation of NF-κB and generation of more TNFα. In addition, FFAs activate the stress/inflammatory kinases JNK and IKKβ. ↑, up-regulation; ↓, suppression. Gastroenterology 2006 131, 934-945DOI: (10.1053/j.gastro.2006.05.054) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 2 Regulation of NASH and IR: involved mediators and pathways. TNFα and other cytokines such as IL-6 are involved in the generation of IR. Other factors of the immune system such as SOCS-proteins (1, 2, and 7) also are involved in these processes. SOCS-1 and SOCS-3 can link IRSs to ubiquitin-mediated degradation pathways and also to an increase in the key regulator of fatty acid synthesis in liver, the transcription factor SREBP-1c. In recent years, critical intracellular pathways have been identified that are involved in the molecular pathogenesis of IR. Endoplasmic reticulum (ER) stress and various kinases such as JNK and IKKβ, are of critical importance because they not only activate inflammatory pathways but also attenuate insulin signaling. ER stress leads to suppression of insulin-receptor signaling through activation of JNK and the subsequent serine phosphorylation of IRS-1. Gastroenterology 2006 131, 934-945DOI: (10.1053/j.gastro.2006.05.054) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions